Nonpolio Enterovirus Surveillance -- United States,
January-October 1984
Through October 1984, 896 nonpolio enterovirus (NPEV) isolates
have been reported in the United States through CDC's enterovirus
surveillance system. This is substantially lower than the 1,415
isolates reported for the same period in 1983. The five most
frequently reported NPEV types this year have been Echovirus 9
(170/896; 19.0%), Echovirus 30 (91/896; 10.2%), Coxsackievirus B5
(89/896; 9.9%), Echovirus 11 (72/896; 8.0%), and Coxsackievirus A9
(69/896; 7.7%). The five most common NPEV types in each of the
U.S.
regions are listed in Table 6.
Reported by Respiratory and Enterovirus Br, Div of Viral Diseases,
Center for Infectious Diseases, CDC.
Editorial Note
Editorial Note: Earlier this year, it was predicted that five NPEV
types (Echoviruses 9 and 7 and Coxsackieviruses A9, B4, and B5)
would
be frequently isolated in the United States based on early
isolation
data from three U.S. regions (1). To date, these types make up 421
(47.0%) of 896 of all reported NPEV isolates, and all five types
have
been among the 10 most commonly reported types in the United States
this year. In years (such as 1984) when fewer than 1,800
enteroviruses are reported, a retrospective CDC study demonstrated
that fewer than half of all NPEV reported are predictable; in years
with 1,800 or more enteroviruses reported, over 69% of reported
NPEV
can be predicted.
Disclaimer
All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
